Ramdev's Patanjali Ayurved Denies Receiving Notice from MCA, Says ‘Examining Appropriate Action’

India’s fast-growing FMCG giant Patanjali Ayurved, led by yoga guru Baba Ramdev, has recently come under scrutiny after reports emerged suggesting that the Ministry of Corporate Affairs (MCA) had issued a notice to the company. In a prompt response, Patanjali Ayurved denied receiving any official notice, stating that they are currently “examining appropriate legal action” regarding the matter.

This blog post delves into the details surrounding the issue, the company's official stance, and the implications it may have on the Indian FMCG landscape.

Background of the Issue

On May 31, 2025, media reports circulated claiming that the Ministry of Corporate Affairs had sent a formal notice to Patanjali Ayurved over potential regulatory discrepancies. The alleged notice was said to involve compliance matters related to financial disclosures and consumer protection guidelines.

However, in a strongly-worded statement, Patanjali Ayurved dismissed these reports and clarified that no such communication has been received by the company. They expressed concern over what they termed as a “malicious narrative” being spun in the public domain.

Company’s Official Statement

In their official release, a spokesperson for Patanjali Ayurved said:

“We categorically deny receiving any notice from the Ministry of Corporate Affairs. These media reports are misleading and defamatory. We are currently examining appropriate legal action against the parties involved in spreading this misinformation.”

The company also reiterated its commitment to transparency, compliance, and ethical business practices.

Timeline of Key Events

Possible Reasons for the Alleged Notice

While the existence of the MCA notice remains unconfirmed, speculations have emerged about the potential causes that might have triggered regulatory attention.

Common Concerns with FMCG Companies

• Product Labeling Issues: Misleading health claims or unapproved ingredients.

• Consumer Complaints: Cases related to deceptive advertising or poor quality.

• Financial Irregularities: Inaccuracies in balance sheets or annual returns.

Given Patanjali’s expansive product line—from herbal medicines to processed foods—regulatory scrutiny is not uncommon. However, the company has so far maintained a clean record in most areas.

Impact on Patanjali’s Brand and Market Position

Despite the controversy, Patanjali continues to hold a strong market presence. The brand has built itself on the foundation of traditional Ayurvedic knowledge, nationalistic pride, and affordable pricing.

Current Market Standing

The current episode, if not handled delicately, could affect stakeholder trust and investor sentiment. However, Patanjali’s quick response and potential legal action may help them mitigate reputational damage.

What Lies Ahead?

With the company already exploring legal avenues, this issue could potentially escalate into a broader debate about media responsibility, corporate transparency, and public trust. Regardless of the outcome, Patanjali’s future actions will be closely watched by both industry experts and consumers alike.

Steps Patanjali May Take:

1. Issue Legal Notices to Media Houses

2. Request Formal Clarification from MCA

3. Strengthen Public Relations Efforts

4. Audit Compliance Documentation

5. Engage with Consumer Forums Proactively

Conclusion

While controversy is not new to major corporations, especially those with high visibility like Patanjali Ayurved, the current issue underscores the importance of verified information and responsible journalism. Whether or not an MCA notice was genuinely issued, the company’s robust denial and legal exploration signify a decisive stance to protect its integrity.